While some publications failed to test the integrity of the endothelial cell monolayer in the system before the tumor cells were introduced [37], the analysis of the VE-Cadherin expression was a well-established method for microfluidic devices that used endothelial cells in order to examine the integrity of the endothelial cell monolayer. This evidence concerns the gene CDH5 and neoplasm.